Business · 22/07/19961 min read

FDA Extends Comment Period on Labeling of Over-the-Counter Oral Medications

The Food and Drug Administration (FDA) is extending the comment period on proposed rulemaking to amend labeling requirements for over-the-counter oral medications containing calcium, magnesium, or potassium until September 20, 1996, in response to a request for an additional extension.